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This essay describes my thoughts on the role of CAM in cancer and was provoked by some ugly scenes
when I was debating the subject at Kings College London. I conclude that when one analyzes what CAM
truly has to offer compared with the best of conventional medicine, then CAM does more harm than
good. However it is up to modern medical practitioners to raise their game in order to prevent practi-
tioners of alternative medicine slipping into the gaps left unattended by our profession.
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On the 28th of April 2009 I took part in a debate organized by
Vivek Datta, President of the Kings College London (KCL) Social
Medicine Society. The motion before the ﬂoor was: ‘‘This house
believes that complementary and alternative therapies do more
harm than good.’’ Simon Singh (author of ‘‘Fermat’s last equation’’
and co-author of ‘‘Trick or Treatment?: Alternative Medicine on
Trial’’) and myself were proposing the motion whilst Prof George
Lewith, Professor of Health Research, CAM Group, University of
Southampton, and Prof David Peters, Professor Integrated Health,
University of Westminster were opposing the motion. I assumed
that we would be debating the topic in front of a group of medical
students yet at ﬁrst glance the audience looked a little ‘‘over-ripe’’
to beundergraduates.Within a short timeof getting tomy feet I real-
ized that the hall had been packed by about 100 practitioners of
alternative medicine. Their behavior was shameful with much boo-
ing and jeering and ad homonym attacks. At one point I was accused
of being in the pocket of the pharmaceutical industry. This nadir of
personal abuse exempliﬁed the intellectual bankruptcy of the bused
in bigots. Apart from bad manners the experience demonstrated
another aspect of the mind-set of the proponents of medical
quackery, in that they have not been trained to have their ideas chal-
lenged or subjected to close scrutiny, unlike clinical scientists who
have imbibed this healthy attitude in their mother’s milk. In the
end Simon Singh and I lost the debate although we achieved quite
a satisfactory swing in the proportion of votes cast before and after
the debate so it was a moral victory of sorts. As I was not allowed
to complete my argument in front of this rent-a-crowd I welcomed
the invitation from the IJS to present my case in full.
2. What are the needs of patient’s with life threatening
disease?
Patients diagnosed with cancer have many needs. The diagnosis
comes as a shock and may be for the ﬁrst time, the individual isElsevier Ltd on behalf of Surgical Afacing up to her mortality. So before health service providers
even think about the role of medicine, they must consider patients’
requirement for moral and spiritual support. At times like this,
a close supportive family and membership of a faith community
are invaluable. Sadly there are many cancer sufferers who lack
family support and have no spiritual mentor. Perhaps one explana-
tion of the growth in the interest in CAM is the unmet need of the
patient when conventional medical practice fails to ﬁll this aching
void.
The next need for cancer subjects is to be free of whatever symp-
toms plague their life, as a result of the disease. Of course, in the
early stages the patients may be symptom free but, in the later
stages, suffering is common from pain, nausea and weakness. The
science of pain control is well established and palliative care for
those close to the end is a well-developed specialty thanks to the
British hospice movement. In addition there may well be a role
for interventions such as therapeutic massage, acupuncture and
counselling to help the patient feel better. Relatively new is the
discipline of ‘‘Psycho-social oncology’’ which aims to identify and
manage the more subtle subjective symptoms of cancer such as
anxiety and depression. This ﬁeld of activity emerged about 20
years ago with the development of psychometric instruments,
addresses the psychological, social, spiritual and behavioural
dimensions of being afﬂicted with the diagnosis of cancer from
both perspectives: the one of the patient and the ones of the
members of his or her social network. Furthermore there exists
a mind body nexus that, in theory, could be modulated to inﬂuence
the natural course of the disease so that if the patient ‘‘feels better’’
it might indirectly help them ‘‘get better’’.
The third need of cancer victims is to be cured or at least have
their lives prolonged.
3. The history of cancer treatment
From the years 200 to 1800 CE, following the teachings of
Aristotle and Galen, cancer was believed to be a consequence ofssociates Ltd.
Editorial / International Journal of Surgery 7 (2009) 409–412410the coagulation of ‘‘black bile’’ (melancholia) in the target organ.
Black bile was one of the four metaphysical humours (black bile,
yellow bile, phlegm and blood) that needed to be in balance for
perfect health. The therapeutic responses to this belief were purga-
tion (enemas), leaching, cupping, bloodletting and extreme diets.
There was never any evidence that the treatments worked but
undoubtedly the patient’s suffering was increased. Such ‘‘ancient
wisdom’’ is best conﬁned to the rubbish bin of history. In the last
200 years we have learnt much about the exquisite mechanisms
of the body at molecular, cellular, whole organ and whole person
levels. These realities are more beautiful, awesome and mysterious
than ever dreamt of in Galen’s philosophy.
In the late 19thC with the development of anaesthesia and
antisepsis surgery began to replace irrational nostrums. Not long
after this radiotherapy was introduced that increased the chances
of local control of cancer. These early successes in functional and
symptomatic relief lead to a period of complacency in the medical
profession that began to be shaken with the development of effec-
tive (albeit toxic) medical regimens about 30 years ago. At the
same time, the randomised controlled trial (RCT) was introduced
to critically evaluate combinations of these three modalities
measuring both efﬁcacy (improvement in survival) and tolerability
(side effects and quality of life). Using this approach we have
made slow incremental improvements and can now negotiate
with our patients ‘‘trade offs’’ between increasing length of life
and the toxicity/side effects of the treatments with a degree of
precision and individualization that increases with each trial
completed.
We have still a long way to go and once again there is no room
for complacency. The challenge for the oncologists of today is to get
the correct balance between the curiosity (scientiﬁc interest in
helping patients of the future) and the compassion (helping
patients of the present) in order to reach the optimal efﬁciency
level of care both in routine clinical practice and for the patient
treated in the context of clinical research. Against this background
let us consider the meaning of complimentary and alternative
medicine (CAM).
4. Semantics and the deﬁnitions of CAM
The English language has a rich and beautiful vocabulary. All
these wonderful words have precise meaning and we tamper
with them at our peril. George Orwell’s terrifying book 1984
illustrates the ultimate triumph of the evil of a totalitarian
state. By the simple device of distorting the language as to
make it impossible to even harbour subversive thoughts, ‘‘Big
Brother’’ ruled absolutely. It saddens me to witness how the
language is being debased by a pseudo-culture that encourages
transient values and transient meanings to our vocabulary. The
same worry concerns the use of the three words, alternative,
complementary and holistic, when applied to the practice of
medicine.
The ﬁrst question you have to ask about ‘‘alternative’’ is –
alternative to what? Proponents of alternative medicine will
describe the practice of doctors in the National Health Services,
both in primary and tertiary care, as ‘‘orthodox’’, ‘‘mainstream’’,
‘‘Western’’, ‘‘reductionist’’, and so on. In return the practitioners
of conventional medicine view ‘‘alternative/unconventional’’
medicine as a series of comprehensive health belief systems,
superﬁcially with little in common, yet sharing beliefs in meta-
physical concepts of balance and similarities which date back to
Galenic doctrine from the second century A.D, or oriental mysti-
cism 2000 years older. So in this parallel universe of alternative
medicine, treatments are based on metaphysical concepts, rather
than orthodox physiology and biochemistry. Yet it has to beaccepted that each view of the other, is to some extent pejorative
and if we are to establish a dialogue between the champions on
either side of this conceptual divide we must show mutual trust
and mutual respect. Perhaps for the time being we might blur
these distinctions by using the word ‘‘unproven’’ which can apply
equally well to therapeutic interventions on each side. Of course,
the issue of the deﬁnition of ‘‘proof’’ then raises problems that I
will address later.
Next we must consider the deﬁnition of ‘‘complementary’’. The
Oxford English dictionary deﬁnes the word as, ‘‘that which
completes or makes perfect, or that which when added completes
a whole.’’ In other words, whilst modern medical science strug-
gles to cure patients, complementary medicine helps patients to
feel better, and who knows, by feeling better the act of healing
itself may be complemented. Some complementary approaches
may be placebos, and the touch of the ‘‘healer’’ or the hand of
the massage therapist could be guided by strange belief systems
that are alien to modern science. Providing the intention is to
support the clinician in his endeavours rather than compete in
the relativistic market place of ideas one might set aside these
concerns.
Finally ‘‘holism’’, a slippery word whose ownership is competed
for by both sides of the therapeutic divide. The word, holism, was
coined by General Jan Smuts in 1926. He used the word to describe
the tendency in nature to produce wholes from the ordered
grouping of units (holons). Chambers 20th century dictionary
describes holism in a precise and economic way as follows
‘‘Complete and self-contained systems from the atom and the cell
by evolution to the most complex forms of life and mind’’. It can
be perceived then that the concept of holism is complex and exqui-
site, and as an open system lends itself to study and experimenta-
tion. As such it should be a concept that unites us rather than
a continuing source of dispute.
To do justice to General Jan Smuts’ deﬁnition of the word
holism, we have to start at the molecular level, and then from these
basic building blocks attempt to reconstruct the complex organism
which is the human subject living in harmony within the complex
structure of a modern democratic nation state.
The basic building block of life has to be a sequence of DNA that
codes for a speciﬁc protein. These DNA sequences or genes are
organised within chromosomes forming the human genome. The
chromosomes are packed within the nucleus with a degree of
miniaturisation, which is awe-inspiring. The nucleus is a holon
looking inwards at the genome and outwards at the cytoplasm
of the cell. The cell is a holon that looks inwards at the proteins,
which guarantee its structure and function contained within its
plasma membrane, and at the energy transduction pathways con-
tained within the mitochondria, which produce the fuel for life. As
a holon the cell looks outwards at neighbouring cells of a self-
similar type, which may group together as glandular elements,
but the cellular holon also enjoys cross talk with cells of a different
developmental origin. These glandular elements group together as
a functioning organ which is holistic in looking inwards at the
exquisite functional integrity of itself, and outwards to act in
concert with the other organs of the body. This concert is orches-
trated at the next level in the holistic hierarchy through the neuro-
endocrine and immunological control mediated via the hypotha-
lamic pituitary axis, the thyroid gland, the adrenal gland, the
endocrine glands of sexual identity, and the lympho-reticular
system that can distinguish self from non-self. Even this notion
of selfness is primitive compared with the next level up the hier-
archy where the person exists in a conscious state somewhere
within the cerebral cortex, with the mind, the great-unexplored
frontier, which will be the scientiﬁc challenge of doctors in the
new millennium.
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practised at the highest level in the hierarchy that governs the
human organism. Providing the ‘‘complementary’’ practitioner
concentrates on making the patient feel better and spiritually
at ease, then his/her position is secure in the modern world.
We would also urge proponents of alternative and complemen-
tary medicine to appreciate that the holistic system is an open
system that lends itself to the experimental method. There is
much research that is urgently required to investigate the
psychosomatic aspects of disease, and the spiritual dimension
to healing.5. To what extent does the widespread adoption of CAM
reﬂect the unmet needs of the cancer patient?
The practitioners of evidence-based medicine can, no longer
ignore the prevalence of CAM usage in the world. This is relevant
to medical practice in a number of ways. First of all it must reﬂect
the unmet needs of cancer patients. Secondly we have a duty of
care to protect our patients from the dangers of remedies that
might be toxic, interact unfavourably with our own medications
or be promoted as alternatives to evidence based treatment.
The massive emotional impact after the disclosure of diagnosis
of cancer can results in fear, confusion and isolation. The fear can
be countered by reassurance and the offer of hope by the respon-
sible clinician. Hope is not a promise but a state of mind. Confusion
can be countered by improvement in the communication skills of
the practitioner. I welcome the developments in the undergraduate
and post-graduate curricula designed to teach professional devel-
opment and communication skills. At the same time the negative
judgment on the medical profession made by some CAM practi-
tioners and representatives of the media regarding the concern
about the subjective outcomes of medical care must be challenged.
It should be remembered that surgical and medical oncologists
were the ﬁrst to invent, critically evaluate and implement quality
of life measurement tools. In addition, counselling is well accepted
by the nursing and the medical profession. Here for a start is a non-
controversial way of building bridges among all professionals
involved.
Beyond that, the popularity of CAM might reﬂect the time
constraints of medical practitioners in understaffed and under-
funded government health services, unrealistic expectations of
the patient of the best that modern medicine can offer, a despera-
tion of the patient or her family in facing up to the terminal stages
of the disease or even a cultural/philosophical objection to modern
medicine which is one component of the post modern relativistic
philosophy popular in parts of Europe today.6. Religious and spiritual support
All ‘‘believers’’ and ‘‘non-believers’’ accept that there is a tran-
scendental component to life that can offer comfort, support and
an explanation for the ‘‘human condition’’. Atheists might gain
this through ﬁne art, music, literature, poetry and theatre.
‘‘Believers’’, in addition to their access to the arts, may achieve
the transcendental via membership of a faith community or by
seeking their spiritual salvation through any number of ‘‘new-
age’’ belief systems. However spiritual comfort is achieved,
focusing on the transcendental enhances a sense of personal
control, builds self esteem, offers a meaning to both life and death,
provides comfort and hope and if ‘‘believers’’ are members of an
organized faith community, they will have access to community
support. Of course belief in God and belief in modern medicine
are not mutually exclusive. However, there can be a down side toall this, if religiosity is confused with magic or subverted to be in
conﬂict with a doctor’s duty of care.
Even the word ‘‘healing’’ is open to semantic abuse using the
term in a loose way to imply ‘‘healing of the spirit’’ rather than
the common usage where ‘‘to heal’’ is meant ‘‘to cure’’. Some char-
latans appear content to allow this misconception to stand uncor-
rected yet deny ever claiming that their interventions contributed
to a cure. Others, who truly believe in their healing powers as
a cure, often invoke a view of a lost ‘‘Golden age’’ when nature
offered a cure for all human ailments. In this respect medical prac-
titioners must take a robust position. There never was such
a ‘‘Golden age’’, nature is neutral and ‘‘left to nature’’ would mean
observing the natural history of cancer. At the same time ‘‘golden
age’’ beliefs imply a denial of progress. Most sinister of all are the
faith systems that look upon disease as ‘‘God’s will’’ and cancer as
some kind of punishment, in which case ‘‘healing’’ can only follow
prayer. This is an evil doctrine equivalent to those who claimed that
the victims of the tsunami disaster reﬂected God’s anger at man-
kind’s corruption.
7. The rules of evidence and the nature of ‘‘proof’’
In order to promote a dialogue and for the sake of our patients, it
would be helpful to lay to rest the myth that doctors working in the
conventional health care systems are knowingly denying patients
the proven beneﬁts of therapeutic strategies developed by propo-
nents of CAM. If there is evidence for the claims linked to an inter-
vention, then it doesn’t matter what their point of origin or
provenance might be. In return, if approached by professionals
engaged in CAM for help in testing whether their favoured inter-
vention is of value, then it should be the responsibility of the
medical establishment to assist the best they can. What has to be
agreed, however, is there cannot be a double standard. In the broad-
est terms there are three categories of research design involving
cancer patients.
Firstly there is ‘‘Qualitative research’’ which usually has the
intention of capturing the individual patient’s experience and
deﬁning their needs. This in itself does not provide evidence of
efﬁcacy of an individual treatment but should be used to set
the agenda for other research models. Next there is observational
research that is the tool of epidemiologists. They might provide
clues to suggest therapies e.g. dietary intervention, or more
importantly on the prevention of disease. Finally there is the clin-
ical trial. It is at this point we have to consider the randomised
controlled trial (RCT). This study design is sufﬁciently robust to
cope with the extraordinary variability and to some extent unpre-
dictability of cancer. The properly designed and conducted RCT
therefore can control for case mix, selection bias, observer bias
and placebo effect and is sufﬁciently malleable to accommodate
the needs of CAM. For example if the CAM intervention is aimed
at improving quality of life (QOL) or patients satisfaction then
these can be deﬁned as primary endpoints and measured by
one or more of the many psychometric instruments that have
already been validated. If the primary endpoint is not already
covered by one of the instruments, for example in the spiritual
domain, then the onus should be on its proponent to develop
a new instrument; remembering Lord Kalvin’s aphorism ‘‘if it
exists then you can measure it’’. Another problem that has to be
accommodated concerns the individualization of treatment often
used as an excuse to avoid RCTs. Here again a robust design would
allow randomisation of the ‘‘individualized’’ intervention against
a non-individualized ‘‘one size ﬁts all’’ treatment, and let the
best man win.
Clinical trials often generate results that are not entirely in
agreement with each other. Thus it is misleading to rely on the
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words, we have to consider the totality of the available data.
Systematic reviews (SR) are attempts to summarize and evaluate
the totality of the available evidence of a pre-deﬁned nature on
a certain subject. All the components of the approach and assess-
ment are made explicit so that the result is entirely reproducible.
If statistical pooling is used, this is called a meta-analysis. The
strength of systematic reviews is that they minimize selection
(i.e. the emphasis on the trials that reinforce a prejudice) and
random biases (i.e. the play of chance). Thus they can provide
the most objective evidence on a given subject and are a sound
basis for clinical decisions. The same standards of quality must
be used for CAM and for mainstream medicine. A double standard
is not acceptable.
I believe that, should a promising treatment one day emerge
from ‘‘alternative’’ therapy, it should be investigated without delay
by oncologists and adopted into routine care as soon as the data
supporting its use are sufﬁciently strong. For example plant-based
cancer medications such as Vincristin and Vinblastin (both extract
from the plant Vinca rosea) or Taxol (Taxus baccata) are already in
routine use.8. Does CAM do more harm than good?
The motion before the house might be considered an overstate-
ment bearing in mind the content of this paper so far but recent
events have provided me with much cause for alarm. I am often
accused of tilting at windmills; and hey, what’s wrongwith offering
placebos for the worried well with self limiting conditions? Well
ﬁrstly it is considered unethical for modern medical practitioners
to sink to this kind of deception that denies the patient his
autonomy. Secondly, by opening the door to irrational medicine
alongside evidence-based medicine, we are poisoning the minds
of the public. Finally, if we don’t put a break on the increasing
self-conﬁdence of the CAM establishment, they will cease to limit
their attention to self-limiting or non-speciﬁc maladies. Already
an investigative journalist for ‘‘Newsnight’’ has exposed the will-
ingness of homeopathic chemists to offer homeopathic prophylac-
tics for malaria.1 Finally and worst of all, on world AIDS day, the
Society of homoeopaths in London, hosted a conference on the
treatment and prevention of HIV/AIDS by using water with
a remarkable memory.29. Conclusion
Holism in medicine is an open ended and exquisitely complex
understanding of human biology that over time has lead to spectac-
ular improvements in the length and quality of life of patients with
cancer. This approach encourages us to consider the transcendental
as much as the cell and molecular biology of the human organism.
Alternative versions of CAM dressed up as ‘‘holistic medicine’’ that
offer claims of miracle cures for cancer by impossible dietary regi-
mens, homeopathy or metaphysical manipulation of non existent
energy ﬁelds, are cruel and close to fraudulent acts that deserve
to be criminalized. Such ‘‘alternative’’ versions of holism are arid
and closed belief systems, locked in a time warp, incapable of
making progress yet quick to deny progress in the ﬁeld of scientiﬁc
medicine.Conﬂict of interest
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